Presentation Details:
Session Objectives:
Understand the changes made to federal regulations effecting the operations of Opioid Treatment Programs
Review recent changes to regulations involving buprenorphine prescribing and controlled substance prescribing via Telehealth
Discuss potential implications of these changes on the treatment landscape and how to counsel patients about treatment options.
Presented by:
James Darnton, MD, FASAM
Clinical Assistant Professor
Department of General Internal Medicine
University of Washington School of Medicine
Associate Medical Director
Evergreen Treatment Services
Presentation Transcript: